Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Paget's Disease, Mammary × Medroxyprogesterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 2 Breast Carcinoma In Situ 2 Paget's Disease, Mammary 1 Kidney Neoplasms 1 Hot Flashes 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1

Interventions

Tamoxifen 1 Medroxyprogesterone 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed

BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡